**2026年一份法國試驗計畫書(PRIUM-Cell)**描述了在13例妊娠的胎兒手術中測試臍帶間質幹細胞貼片的計畫,但目前還沒有結果(研究摘要、8)。2026年發表於《Seminars in Pediatric Surgery》的一篇回顧由執行CuRe試驗的團隊撰寫,描述了幹細胞和貼片如何與胎兒手術結合,並指出MOMS試驗所測試的開放式胎兒手術仍是研究最充分的治療,而出生前使用幹細胞到目前為止只在六名嬰兒身上測試過安全性(研究摘要、9)。2026年另一篇領域回顧討論了幹細胞和生物材料可能如何幫助保護和修復受損的脊髓組織,但也指出,儘管動物研究結果令人期待,胎兒修補中的幹細胞做法離常規臨床使用仍很遠(研究摘要、10)。
1.
Boruczkowski D, Zdolińska-Malinowska I. A retrospective analysis of safety and efficacy of Wharton's jelly stem cell administration in children with spina bifida. Stem Cell Reviews and Reports. 2019;15:717-729.
https://doi.org/10.1007/s12015-019-09902-6
2.
Nguyen LT, Le HT, Nguyen KT, Bui HT, Nguyen APT, Ngo DV, Hoang DM, Ngo MD. Outcomes of autologous bone marrow mononuclear cell administration in the treatment of neurologic sequelae in children with spina bifida. Stem Cell Research & Therapy. 2023;14:115.
https://doi.org/10.1186/s13287-023-03349-w
3.
Farmer DL, et al. Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm study. The Lancet. 2026;407:867-875.
https://doi.org/10.1016/S0140-6736(25)02466-3
4.
Athiel Y, et al. Allogenic umbilical cord-derived mesenchymal stromal cells improve motor function in prenatal surgical repair of myelomeningocele: an ovine model study. BJOG. 2024;131(6):759-767.
https://doi.org/10.1111/1471-0528.17624
5.
Athiel Y, et al. Safety and efficacy of human umbilical cord-derived mesenchymal stromal cells in fetal ovine myelomeningocele repair. Stem Cell Research & Therapy. 2024;15:444.
https://doi.org/10.1186/s13287-024-03991-y
6.
Bamberg C, et al. In vivo therapy for prenatal repair of the ovine fetal myelomeningocele model using human umbilical cord-derived mesenchymal stem cells: proof of principle. Journal of Perinatal Medicine. 2026;54(5):881-888.
https://doi.org/10.1515/jpm-2025-0577
7.
Kunpalin Y, et al. Preclinical stem cell therapy in fetuses with myelomeningocele: a systematic review and meta-analysis. Prenatal Diagnosis. 2021;41:283-300.
https://doi.org/10.1002/pd.5887
8.
Guilbaud L, et al. PRIUM-Cell : programme de réparation in utero des myéloméningocèles utilisant des cellules stromales mésenchymateuses [In utero myelomeningocele repair programme using mesenchymal stromal cells]. Gynécologie Obstétrique Fertilité & Sénologie. 2026;54(4):228-233.
https://doi.org/10.1016/j.gofs.2025.10.020
9.
Reynolds E, Rosas D, Wang A, Farmer DL. Fetal myelomeningocele repair: a narrative review of the historical perspective, emerging regenerative therapies, and future directions. Seminars in Pediatric Surgery. 2026;44:151680.
https://doi.org/10.1016/j.sempedsurg.2026.151680
10.
Evangelista A, Ruccolo L, Friuli V, et al. Advances in fetal repair of spina bifida integrating prenatal surgery, stem cells, and biomaterials. Biomedicines. 2026;14:136.
https://doi.org/10.3390/biomedicines14010136
11.
Adzick NS, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. New England Journal of Medicine. 2011;364:993-1004.
https://doi.org/10.1056/NEJMoa1014379
12.
Radmayr C, et al. EAU-ESPU-ERN eUROGEN-ERN ITHACA-ERN ERKNet-IFSBH guidelines on spinal dysraphism in children and adolescents: summary of the guideline. European Urology Open Science. 2026;88:39-53.
https://doi.org/10.1016/j.euros.2026.04.002
13.
Engelborghs S, et al. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;8:111-126.
https://doi.org/10.1016/j.dadm.2017.04.007
15.
Liem NT, Chinh VD, Thinh NT, Minh ND, Duc HM. Improved bowel function in patients with spina bifida after bone marrow-derived mononuclear cell transplantation: a report of 2 cases. American Journal of Case Reports. 2018;19:1010-1018.
https://doi.org/10.12659/AJCR.909801
18.
Hum C, Poliwoda J, Lalu M, et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine. 2026;15(6).
https://doi.org/10.1093/stcltm/szag029
19.
Buijtendijk MFJ, et al. Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations. Cochrane Database of Systematic Reviews. 2024;5:CD014715.
https://doi.org/10.1002/14651858.CD014715.pub2
20.
Salomon LJ, et al. ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan. Ultrasound in Obstetrics & Gynecology. 2022;59(6):840-856.
https://doi.org/10.1002/uog.24888